Novartis, Sandoz In Tangle With Trade Channels Over Direct Drug Sales In India
This article was originally published in The Pink Sheet Daily
Executive Summary
Indian trade organization alleges the companies violated agreements by selling high-value drugs directly to patients, triggering a boycott of their products.